Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLXPF | AZN | AMGN | GILD | VRTX |
| Company | Cybin Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.0500 | 189.52 | 364.74 | 126.72 | 503.76 |
| High | 3.2000 | 196.41 | 375.15 | 131.58 | 529.14 |
| Low | 2.8736 | 189.17 | 363.39 | 126.46 | 501.53 |
| Latest | 3.0200 | 195.15 | 374.15 | 131.27 | 528.04 |
| Change | -0.0400 | +11.29 | +12.82 | +5.30 | +30.03 |
| % Change | -1.31% | +6.14% | +3.55% | +4.21% | +6.03% |
| Volume | 864,300 | 2,379,600 | 2,487,800 | 8,088,800 | 1,855,900 |
| 20-Day Average Volume | 1,094,590 | 2,029,230 | 3,240,630 | 9,496,580 | 1,887,965 |
| Previous Close | 3.0600 | 183.86 | 361.33 | 125.97 | 498.01 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.8482 | 182.78 | 351.13 | 126.12 | 466.08 |
| 20-Day Raw Stochastic | 71.64% | 94.46% | 97.57% | 96.20% | 98.85% |
| 20-Day Relative Strength | 62.45 | 58.78 | 65.78 | 53.67 | 75.36 |
| Weighted Alpha | +130.72 | +34.01 | +27.36 | +13.68 | +25.89 |
| Today's Opinion | N/A | 24% Buy | 56% Buy | 40% Sell | 72% Buy |
| Previous Opinion | N/A | 24% Sell | 56% Buy | 88% Sell | 72% Buy |
| Last Month's Opinion | N/A | 40% Sell | 56% Sell | 40% Sell | 48% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.46% since 07/28/21 | +5.10% since 06/25/26 | +6.05% since 06/25/26 | +6.00% since 06/25/26 | +9.97% since 06/25/26 |
| Low | 2.7300 on 07/29/21 | 183.49 on 07/01/26 | 354.16 on 06/26/26 | 124.19 on 06/30/26 | 482.20 on 06/26/26 |
| High | 3.3800 on 08/02/21 | 196.41 on 07/02/26 | 375.15 on 07/02/26 | 131.58 on 07/02/26 | 529.14 on 07/02/26 |
| 1-Month | |||||
| %Chg | +42.45% since 07/02/21 | +9.97% since 06/02/26 | +13.98% since 06/02/26 | +2.90% since 06/02/26 | +24.22% since 06/02/26 |
| Low | 2.1105 on 07/08/21 | 173.65 on 06/18/26 | 325.98 on 06/03/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 3.3800 on 08/02/21 | 196.41 on 07/02/26 | 375.15 on 07/02/26 | 131.66 on 06/05/26 | 529.14 on 07/02/26 |
| 3-Month | |||||
| %Chg | +79.76% since 05/04/21 | -4.10% since 04/02/26 | +7.53% since 04/02/26 | -6.04% since 04/02/26 | +20.36% since 04/02/26 |
| Low | 1.3429 on 06/01/21 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 3.3800 on 08/02/21 | 207.30 on 04/10/26 | 375.15 on 07/02/26 | 142.97 on 04/09/26 | 529.14 on 07/02/26 |
| 6-Month | |||||
| %Chg | +76.61% since 02/04/21 | +6.56% since 01/02/26 | +14.20% since 01/02/26 | +7.95% since 01/02/26 | +16.79% since 01/02/26 |
| Low | 0.9500 on 03/30/21 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 3.3800 on 08/02/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 529.14 on 07/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 453,224 | 302,659,680 | 201,931,744 | 162,980,896 | 134,019,184 |
| Shares Outstanding, K | 148,598 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 650,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -24,420,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | N/A | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | N/A | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | N/A | 0.24 | 0.41 | 0.32 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 09/27/21 | 07/27/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.86 | 16.35 | 15.05 | 29.61 |